The global antifungal drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The fungal infection in the body is caused due to unhygienic and unclean environments wherein fungal agents thrive. These agents multiply by spreading spores that subsequently lead to infection on the skin (superficial) or when inhaled (systemic)-fungal infections. The fungal infection leads to candidiasis, fungal pneumonia, mucormycosis, and other diseases. These infections are mostly non-lethal but can result in death in rare cases. Antifungal drugs are used to detect and treat fungal pathogens from the body with minimal to no toxic side effects to the body. The major factor for the growth of the market during the include the rising number of patients suffering from hygiene-related diseases in developing countries and developed countries. According to the National Center for Biotechnology Information (NCBI), fungal diseases affect over a billion people every year. Furthermore, the market is driven by the increasing immunity deficient, geriatric population, and rise in exposure to infectious agents due to environmental factors such as pollution.
To Request a Sample of our Report on Antifungal Drug Market: https://www.omrglobal.com/request-sample/antifungal-drug-market
Some key players operating in the market include GlaxoSmithKline plc, Pfizer Inc., and Abbott Laboratories, among others. The market players are eyeing on strengthening their position in the market by adopting various strategies such as mergers and acquisitions, partnerships and collaborations, and new product launches. For instance, in July 2021, Cadila Pharmaceuticals has launched a new triazole antifungal drug Posaconazole for the effective treatment against a wide range of invasive fungal diseases. Additionally, in May 2021, MSN Laboratories has launched a new antifungal drug Posaconazole used in the treatment of mucormycosis or Black Fungus.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2022-2028
Segment Covered-
- By Drug Type
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: GlaxoSmithKline plc, Pfizer Inc., and Abbott Laboratories, among others.
(Get 15% Discount on Buying this Report)
A full Report of Antifungal Drug Market is Available @ https://www.omrglobal.com/industry-reports/antifungal-drug-market
Global Antifungal Drug Market Report by Segment
By Drug Type
- Echinocandins
- Azoles
- Polyenes
- Allylamines
- Others
By Indication
- Candidiasis
- Aspergillosis
- Dermatophytosis
- Others
Global Antifungal Drug Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
